You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

Details for Patent: 11,117,871


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,117,871 protect, and when does it expire?

Patent 11,117,871 protects JESDUVROQ and is included in one NDA.

This patent has six patent family members in six countries.


Drugs Protected by US Patent 11,117,871

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Glaxosmithkline JESDUVROQ daprodustat TABLET;ORAL 216951-001 Feb 1, 2023 DISCN Yes No 11,117,871 ⤷  Subscribe Y Y A METHOD OF TREATING ANEMIA ⤷  Subscribe
Glaxosmithkline JESDUVROQ daprodustat TABLET;ORAL 216951-002 Feb 1, 2023 DISCN Yes No 11,117,871 ⤷  Subscribe Y Y A METHOD OF TREATING ANEMIA ⤷  Subscribe
Glaxosmithkline JESDUVROQ daprodustat TABLET;ORAL 216951-003 Feb 1, 2023 DISCN Yes No 11,117,871 ⤷  Subscribe Y Y A METHOD OF TREATING ANEMIA ⤷  Subscribe
Glaxosmithkline JESDUVROQ daprodustat TABLET;ORAL 216951-004 Feb 1, 2023 DISCN Yes No 11,117,871 ⤷  Subscribe Y Y A METHOD OF TREATING ANEMIA ⤷  Subscribe
Glaxosmithkline JESDUVROQ daprodustat TABLET;ORAL 216951-005 Feb 1, 2023 DISCN Yes No 11,117,871 ⤷  Subscribe Y Y A METHOD OF TREATING ANEMIA ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,117,871

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2018330994 ⤷  Subscribe
Canada 3112277 ⤷  Subscribe
China 111093668 ⤷  Subscribe
European Patent Office 3682884 ⤷  Subscribe
Japan 2020533396 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.